SCIO-469

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	3

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00508768 (ClinicalTrials.gov)	August 2005	27/7/2007	A Study of Oral SCIO-469Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absor ...	A Randomized, Double-Blind, Parallel-Group, Pharmacokinetic Study of Oral SCIO-469(90 mg qd and 30 m ...	Rheumatoid Arthritis	Drug: Oral SCIO-469 capsule	Scios, Inc.	NULL	Completed	18 Years	N/A	Female	16	Phase 1	NULL
2	NCT00089921 (ClinicalTrials.gov)	July 2004	17/8/2004	SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate	A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Ora ...	Arthritis, Rheumatoid	Drug: SCIO-469;Drug: Placebo	Scios, Inc.	NULL	Completed	18 Years	N/A	Both	302	Phase 2	United States
3	NCT00043732 (ClinicalTrials.gov)	July 2002	12/8/2002	Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate	A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of SCIO ...	Rheumatoid Arthritis	Drug: SCIO-469	Scios, Inc.	NULL	Completed	18 Years	N/A	Both	120	Phase 2	United States

First Previous1Next Last